These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 21558430

  • 21. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 22. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 23. Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.
    van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF.
    J Am Soc Nephrol; 2014 Jan; 25(1):150-8. PubMed ID: 24029426
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of membranous glomerulonephritis: analysis of data from the Italian Renal Biopsy Registry].
    Garozzo M, Puliatti D, Battaglia GG.
    G Ital Nefrol; 2011 Jan; 28(4):425-30. PubMed ID: 21809312
    [Abstract] [Full Text] [Related]

  • 25. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [Abstract] [Full Text] [Related]

  • 26. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 May; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 29. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC, Liem M, de Jager DJ, Voormolen N, Sijpkens YW, Rotmans JI, Boeschoten EW, Dekker FW, Grootendorst DC, Halbesma N, PREPARE-1 Study Group.
    Nephron Clin Pract; 2012 May; 121(1-2):c73-82. PubMed ID: 23128440
    [Abstract] [Full Text] [Related]

  • 30. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 May; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 32. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC, Sethi S, Specks U.
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [Abstract] [Full Text] [Related]

  • 33. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 34. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
    Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C.
    Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
    [Abstract] [Full Text] [Related]

  • 35. [Quadritherapy with cyclosporine for membranous lupus nephropathy].
    Matsumoto H, Okada T, Nagaoka Y, Tomaru R, Iwasawa H, Wada T, Nakao T.
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):689-94. PubMed ID: 14631764
    [Abstract] [Full Text] [Related]

  • 36. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 37. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
    Yakupoğlu U, Baranowska-Daca E, Suki WN, Truong LD.
    Transplant Proc; 2004 Oct; 36(1):139-43. PubMed ID: 15013326
    [Abstract] [Full Text] [Related]

  • 38. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G.
    N Engl J Med; 1993 Jul 08; 329(2):85-9. PubMed ID: 8510707
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome.
    Zucchelli P, Ponticelli C, Cagnoli L, Passerini P.
    Nephrol Dial Transplant; 1987 Jul 08; 2(2):73-8. PubMed ID: 3112653
    [Abstract] [Full Text] [Related]

  • 40. Long-term outcome of patients with idiopathic membranous nephropathy.
    Ríhová Z, Merta M, Maixnerová D, Honsová E, Reiterová J, Rysavá R, Zabka J, Tesar V.
    Prague Med Rep; 2006 Jul 08; 107(2):189-98. PubMed ID: 17066739
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.